NDC 67457-928

Dactinomycin

Dactinomycin

Dactinomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Dactinomycin.

Product ID67457-928_0e173ef5-d0f1-41c3-9b64-543195443310
NDC67457-928
Product TypeHuman Prescription Drug
Proprietary NameDactinomycin
Generic NameDactinomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2017-11-09
Marketing CategoryANDA / ANDA
Application NumberANDA203385
Labeler NameMylan Institutional LLC
Substance NameDACTINOMYCIN
Active Ingredient Strength1 mg/mL
Pharm ClassesActinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 67457-928-02

1 VIAL, SINGLE-DOSE in 1 CARTON (67457-928-02) > 1 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2019-06-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67457-928-02 [67457092802]

Dactinomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA203385
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-06-20

Drug Details

Active Ingredients

IngredientStrength
DACTINOMYCIN.5 mg/mL

Pharmacological Class

  • Actinomycin [EPC]
  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Protein Synthesis Inhibitors [MoA]

NDC Crossover Matching brand name "Dactinomycin" or generic name "Dactinomycin"

NDCBrand NameGeneric Name
39822-2100dactinomycindactinomycin
42658-008Dactinomycindactinomycin
55150-431DACTINOMYCINDACTINOMYCIN
55150-928DACTINOMYCINDACTINOMYCIN
66993-489DactinomycinDactinomycin
67457-513DactinomycinDactinomycin
67457-928DactinomycinDactinomycin
71288-129DactinomycinDactinomycin
55292-811Cosmegendactinomycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.